Alzheimer's Disease (AD) is a common neurodegenerative disease for which no treatment or preventative measure exist. Affected individuals eventually require institutional care and invariably die from disease-related conditions. Over 3 million individuals are affected in the US at an annual cost of over $50 billion/year. Although onset can occur as early as the 3rd decade of life, AD is a disease of the elderly; as many as 10% of those over 65 yrs and 50% of those over 85 yr have AD. AD may be related to athe normal aging; autopsies of cognitively normal elderly persons show a low density of amyloid plaques, neurofibrillary tangles, features characteristic of AD. Therefore, studies of AD are important for both solving the disease and for better understanding normal aging. Defective genes are responsible for AD in some families. One AD gene is the amyloid precursor gene (APP) on chromosome 21. APP mutations cause autosomal dominant familial AD (FAD) in some early-onset kindreds. However, in the majority of early-onset families (90-95%) and in late-onset families, FAD is not caused by APP mutations. We used linkage analysis to identify an early-onset FAD locus on chromosome 14. This locus accounts for FAD in most of the early-onset kindreds which do not have APP mutations. We propose to identifying and clone the chromosome 14 gene using positional cloning techniques. Polymorphic markers will be identified for this region and mapped using the CEPH panel. These markers will be used to refine the position of the chromosome 14 FAD locus by linkage analysis. We will generate a radiation hybrid cell panel and a pulse field gel electrophoresis physical map of the FAD region for fine- scale mapping. Once the location has been refined, the corresponding DNA will be cloned, primarily using YAC clones, and a contig assembled. Genes in this contig will be identified and screened by DNA sequence analysis for FAD mutations. Once identified, the gene's function will be sought to understand its role in AD pathogenesis and possibly normal aging. Identification of the chromosome 14 gene may also help resolve the role of genes in late-onset AD.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
5R01AG011762-02
Application #
2052974
Study Section
Neurology C Study Section (NEUC)
Project Start
1994-06-01
Project End
1999-04-30
Budget Start
1995-05-15
Budget End
1996-04-30
Support Year
2
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of Washington
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Ryman, Davis C; Acosta-Baena, Natalia; Aisen, Paul S et al. (2014) Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis. Neurology 83:253-60
Kay, D M; Stevens, C F; Hamza, T H et al. (2010) A comprehensive analysis of deletions, multiplications, and copy number variations in PARK2. Neurology 75:1189-94
Melrose, H L; Dächsel, J C; Behrouz, B et al. (2010) Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice. Neurobiol Dis 40:503-17
Choi, Yoonha; Wijsman, Ellen M; Weir, Bruce S (2009) Case-control association testing in the presence of unknown relationships. Genet Epidemiol 33:668-78
Sieh, Weiva; Choi, Yoonha; Chapman, Nicola H et al. (2009) Identification of novel susceptibility loci for Guam neurodegenerative disease: challenges of genome scans in genetic isolates. Hum Mol Genet 18:3725-38
Wijsman, Ellen M; Sung, Yun Ju; Buil, Alfonso et al. (2007) Summary of Genetic Analysis Workshop 15: Group 9 linkage analysis of the CEPH expression data. Genet Epidemiol 31 Suppl 1:S75-85
Sieh, Weiva; Yu, Chang-En; Bird, Thomas D et al. (2007) Accounting for linkage disequilibrium among markers in linkage analysis: impact of haplotype frequency estimation and molecular haplotypes for a gene in a candidate region for Alzheimer's disease. Hum Hered 63:26-34
D'Souza, Ian; Schellenberg, Gerard D (2006) Arginine/serine-rich protein interaction domain-dependent modulation of a tau exon 10 splicing enhancer: altered interactions and mechanisms for functionally antagonistic FTDP-17 mutations Delta280K AND N279K. J Biol Chem 281:2460-9
Wijsman, Ellen M; Daw, E Warwick; Yu, Xuesong et al. (2005) APOE and other loci affect age-at-onset in Alzheimer's disease families with PS2 mutation. Am J Med Genet B Neuropsychiatr Genet 132B:14-20
Wijsman, Ellen M; Daw, E Warwick; Yu, Change-En et al. (2004) Evidence for a novel late-onset Alzheimer disease locus on chromosome 19p13.2. Am J Hum Genet 75:398-409

Showing the most recent 10 out of 28 publications